Pharma & Biotech

After a remarkable performance this year, Assembly Biosciences appears well-positioned for its next growth phase. Distinguished from many cash-strapped competitors...

Following a disastrous performance this year that saw its value nearly halve since January, Redcare Pharmacy investors are searching for...

A substantial purchase by a major shareholder has propelled Standard BioTools stock significantly higher. Casdin Capital, the company's largest investor,...

The Danish pharmaceutical giant Novo Nordisk is navigating a challenging period that would have seemed improbable just two years ago....

Time is running out for investors in CureVac as the company's independence draws to a close. The German biopharmaceutical firm,...

After being largely dismissed by investors due to plummeting COVID-19 revenue and looming patent expirations, pharmaceutical giant Pfizer is suddenly...

The German biotech firm BioNTech finds itself at a pivotal moment. As the company navigates the final stages of its...

The market delivered a harsh verdict on InnoCan Pharma's latest financial performance, sending the Canadian pharmaceutical technology company's stock sharply...

Investors in Ocugen are witnessing a potential turning point following a period of significant volatility. The catalyst for renewed optimism...

Tango Therapeutics is capturing market attention with a powerful upward move, propelled by significant clinical developments and a landmark achievement...